Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
2002 6
2003 5
2004 6
2005 12
2006 15
2007 11
2008 18
2009 22
2010 24
2011 26
2012 24
2013 33
2014 34
2015 26
2016 23
2017 25
2018 30
2019 20
2020 25
2021 33
2022 21
2023 19
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

389 results

Results by year

Filters applied: . Clear all
Page 1
HLA-DRB1 is associated with cefaclor-induced immediate hypersensitivity.
Park SY, Park SY, Seo S, Kwon HS, Kim SH, Kim SH, Park HK, Chang YS, Kim CW, Lee BJ, Park HS, Cho YS, Oh HB, Ostrov DA, Won S, Kim TB. Park SY, et al. Among authors: chang ys. World Allergy Organ J. 2024 Apr 13;17(5):100901. doi: 10.1016/j.waojou.2024.100901. eCollection 2024 May. World Allergy Organ J. 2024. PMID: 38638799 Free PMC article.
Characterization of Codeine Treatment Responders Among Patients with Refractory or Unexplained Chronic Cough: A Prospective Real-World Cohort Study.
Oh JY, Kang SY, Kang N, Won HK, Jo EJ, Lee SE, Lee JH, Shim JS, Kim YC, Yoo Y, An J, Lee HY, Park SY, Kim MY, Lee JH, Kim BK, Park HK, Kim MH, Kim SH, Kim SH, Chang YS, Kim SH, Lee BJ, Chung KF, Cho SH, Song WJ; Korean Chronic Cough Registry Study Group. Oh JY, et al. Among authors: chang ys. Lung. 2024 Apr;202(2):97-106. doi: 10.1007/s00408-024-00674-6. Epub 2024 Feb 27. Lung. 2024. PMID: 38411774
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials.
Maurer M, Ensina LF, Gimenez-Arnau AM, Sussman G, Hide M, Saini S, Grattan C, Fomina D, Rigopoulos D, Berard F, Canonica GW, Rockmann H, Irani C, Szepietowski JC, Leflein J, Bernstein JA, Peter JG, Kulthanan K, Godse K, Ardusso L, Ukhanova O, Staubach P, Sinclair R, Gogate S, Thomsen SF, Tanus T, Ye YM, Burciu A, Barve A, Modi D, Scosyrev E, Hua E, Letzelter K, Varanasi V, Patekar M, Severin T; PEARL-1 and PEARL-2 trial investigators. Maurer M, et al. Lancet. 2024 Jan 13;403(10422):147-159. doi: 10.1016/S0140-6736(23)01684-7. Epub 2023 Nov 23. Lancet. 2024. PMID: 38008109 Clinical Trial.
Epithelial Barrier Theory: The Role of Exposome, Microbiome, and Barrier Function in Allergic Diseases.
Losol P, Sokolowska M, Hwang YK, Ogulur I, Mitamura Y, Yazici D, Pat Y, Radzikowska U, Ardicli S, Yoon JE, Choi JP, Kim SH, van de Veen W, Akdis M, Chang YS, Akdis CA. Losol P, et al. Among authors: chang ys. Allergy Asthma Immunol Res. 2023 Nov;15(6):705-724. doi: 10.4168/aair.2023.15.6.705. Allergy Asthma Immunol Res. 2023. PMID: 37957791 Free PMC article. Review.
Baseline Cohort Profile of the Korean Chronic Cough Registry: A Multicenter, Prospective, Observational Study.
Jo EJ, Lee JH, Won HK, Kang N, Kang SY, Lee SE, Lee JH, Kim MY, Shim JS, An J, Yoo Y, Park SY, Kim BK, Moon JY, Park HK, Kim MH, Kwon HS, Kim SH, Kim SH, Chang YS, Kim SH, Birring SS, Lee BJ, Song WJ. Jo EJ, et al. Among authors: chang ys. Lung. 2023 Oct;201(5):477-488. doi: 10.1007/s00408-023-00644-4. Epub 2023 Sep 2. Lung. 2023. PMID: 37658853
389 results